3440.10 with Changes - Navy Medicine - U.S. Navy
3440.10 with Changes - Navy Medicine - U.S. Navy
3440.10 with Changes - Navy Medicine - U.S. Navy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
BUMEDINST <strong>3440.10</strong><br />
20 Nov 2008<br />
2. MTFs shall participate in the exercise planning process <strong>with</strong> the region, installation, and<br />
civilian community to provide medically relevant exercise play that will contribute to enhanced<br />
EM interoperability, communications, and overall readiness.<br />
3. MTFs shall generate written AARs to capture lessons learned for future use. AARs shall be<br />
maintained for a minimum of 2 years or until the next Joint Commission/Medical Inspector<br />
General visit (whichever is longer). A copy of the AAR shall be forwarded to the respective<br />
NAVMEDREG. The region will then forward the AAR to BUMED-M3/5 which is responsible<br />
for coordination <strong>with</strong> NOMI.<br />
4. Exercise scenarios should consider the full spectrum of possible hazards and meet requirements<br />
set forth by reference (m) of this section.<br />
5. When an MTF has responded to an actual event of appropriate magnitude, the respective<br />
NAVMEDREG may exempt the MTF from participation in exercises for a period of 6-12<br />
months.<br />
FHP EMP Standard 11: Mitigation and Prevention<br />
1. The <strong>Navy</strong> <strong>Medicine</strong> FHP EMP establishes mitigation and prevention standards and tools for<br />
use by MTF commanders in support of both MTF and installation operations.<br />
2. MTFs shall assist in the processes through which mitigation efforts may diminish the effects<br />
of identified natural and man-made hazards. Such assistance will include providing initial site<br />
survey as well as risk assessment assistance following an incident, as well as granting approval<br />
for re-entry and making recommendations for proper and effective respiratory/personnel<br />
protection for first responders/receivers.<br />
3. Where the capability exists, MTFs shall assist in the identification and confirmation of<br />
disease agents, and the prevention and/or mitigation of morbidity and mortality related to any<br />
all-hazards event. MTFs shall maintain a system and process for collecting, analyzing, and<br />
reporting installation population health that is sensitive to significant fluctuations in normal<br />
disease rates, and is coordinated <strong>with</strong> regional and local civilian public health surveillance<br />
systems. Those epidemiological investigative services will include and interact <strong>with</strong> clinical,<br />
environmental health, criminal/forensic services, as well as the surveillance of animal health,<br />
potable water and food, and air quality. In addition, MTFs shall maintain the capability to<br />
investigate and establish whether an infectious disease outbreak is occurring, and develop a case<br />
definition for victims of the outbreak.<br />
4. In the event of an actual disease outbreak or CBRNE event, MTFs shall utilize their cache of<br />
CPCs and Medical Emergency Response Pharmaceuticals (MERP) to support designated<br />
Category 1 and 5 personnel as well as the general installation population. Furthermore, MTFs<br />
shall provide dispensing and/or immunizing teams to screen and educate patients, dispense<br />
pharmaceuticals, and provide post-exposure immunizations. In addition, MTFs shall be prepared<br />
24 Enclosure (1)